Abstract
BackgroundThe treatment landscape for Acute myeloid leukemia (AML) patients has changed dramatically in recent years, however the majority of patients will eventually relapse. Allogeneic stem cell transplantation has proven the...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
